These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 32398475)
1. Inhibition of MyD88 by LM8 Attenuates Obesity-Induced Cardiac Injury. Liu H; Jia W; Tang Y; Zhang W; Qi J; Yan J; Ding W; Cao H; Liang G; Zhu Z; Zheng H; Zhang Y J Cardiovasc Pharmacol; 2020 Jul; 76(1):63-70. PubMed ID: 32398475 [TBL] [Abstract][Full Text] [Related]
2. Role of TLR4/MyD88/NF-κB signaling pathway in coronary microembolization-induced myocardial injury prevented and treated with nicorandil. Su Q; Lv X; Sun Y; Ye Z; Kong B; Qin Z Biomed Pharmacother; 2018 Oct; 106():776-784. PubMed ID: 29990871 [TBL] [Abstract][Full Text] [Related]
3. Compound LM9, a novel MyD88 inhibitor, efficiently mitigates inflammatory responses and fibrosis in obesity-induced cardiomyopathy. Zheng XY; Sun CC; Liu Q; Lu XY; Fu LL; Liang G; Zhang XH; Chen GZ Acta Pharmacol Sin; 2020 Aug; 41(8):1093-1101. PubMed ID: 32341464 [TBL] [Abstract][Full Text] [Related]
4. Curcumin analogue C66 attenuates obesity-induced myocardial injury by inhibiting JNK-mediated inflammation. Ye L; Chen X; Wang M; Jin L; Zhuang Z; Yang D; Guan X; Samorodov AV; Pavlov VN; Chattipakorn N; Feng J; Wang Y; Luo W; Liang G Biomed Pharmacother; 2021 Nov; 143():112121. PubMed ID: 34474346 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of myeloid differentiation factor-2 attenuates obesity-induced cardiomyopathy and fibrosis. Fang Q; Wang J; Zhang Y; Wang L; Li W; Han J; Huang W; Liang G; Wang Y Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):252-262. PubMed ID: 28965884 [TBL] [Abstract][Full Text] [Related]
6. Blockage of MyD88 in cardiomyocytes alleviates cardiac inflammation and cardiomyopathy in experimental diabetic mice. Luo W; Wu G; Chen X; Zhang Q; Zou C; Wang J; Liu J; Chattipakorn N; Wang Y; Liang G Biochem Pharmacol; 2022 Dec; 206():115292. PubMed ID: 36241098 [TBL] [Abstract][Full Text] [Related]
7. The TIR/BB-loop mimetic AS-1 prevents cardiac hypertrophy by inhibiting IL-1R-mediated MyD88-dependent signaling. Zhu Y; Li T; Song J; Liu C; Hu Y; Que L; Ha T; Kelley J; Chen Q; Li C; Li Y Basic Res Cardiol; 2011 Sep; 106(5):787-99. PubMed ID: 21533832 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of MyD88 attenuates angiotensin II-induced hypertensive kidney disease via regulating renal inflammation. Lin K; Luo W; Yang N; Su L; Zhou H; Hu X; Wang Y; Khan ZA; Huang W; Wu G; Liang G Int Immunopharmacol; 2022 Nov; 112():109218. PubMed ID: 36116148 [TBL] [Abstract][Full Text] [Related]
9. Modified citrus pectin ameliorates myocardial fibrosis and inflammation via suppressing galectin-3 and TLR4/MyD88/NF-κB signaling pathway. Xu GR; Zhang C; Yang HX; Sun JH; Zhang Y; Yao TT; Li Y; Ruan L; An R; Li AY Biomed Pharmacother; 2020 Jun; 126():110071. PubMed ID: 32172066 [TBL] [Abstract][Full Text] [Related]
10. Effects of the TLR4/Myd88/NF-κB Signaling Pathway on NLRP3 Inflammasome in Coronary Microembolization-Induced Myocardial Injury. Su Q; Li L; Sun Y; Yang H; Ye Z; Zhao J Cell Physiol Biochem; 2018; 47(4):1497-1508. PubMed ID: 29940584 [TBL] [Abstract][Full Text] [Related]
11. Danshen (Salvia miltiorrhiza) restricts MD2/TLR4-MyD88 complex formation and signalling in acute myocardial infarction-induced heart failure. Wang X; Guo D; Li W; Zhang Q; Jiang Y; Wang Q; Li C; Qiu Q; Wang Y J Cell Mol Med; 2020 Sep; 24(18):10677-10692. PubMed ID: 32757377 [TBL] [Abstract][Full Text] [Related]
12. MyD88 mediated inflammatory signaling leads to CaMKII oxidation, cardiac hypertrophy and death after myocardial infarction. Singh MV; Swaminathan PD; Luczak ED; Kutschke W; Weiss RM; Anderson ME J Mol Cell Cardiol; 2012 May; 52(5):1135-44. PubMed ID: 22326848 [TBL] [Abstract][Full Text] [Related]
13. Dioscin reduces lipopolysaccharide-induced inflammatory liver injury via regulating TLR4/MyD88 signal pathway. Yao H; Hu C; Yin L; Tao X; Xu L; Qi Y; Han X; Xu Y; Zhao Y; Wang C; Peng J Int Immunopharmacol; 2016 Jul; 36():132-141. PubMed ID: 27135544 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological inhibition of MyD88 suppresses inflammation in tubular epithelial cells and prevents diabetic nephropathy in experimental mice. Zhang QY; Xu SJ; Qian JC; Yang LB; Chen PQ; Wang Y; Hu X; Zhang YL; Luo W; Liang G Acta Pharmacol Sin; 2022 Feb; 43(2):354-366. PubMed ID: 34552217 [TBL] [Abstract][Full Text] [Related]
15. Pretreatment with Wang X; Han C; Qin J; Wei Y; Qian X; Bao Y; Shi W J Interferon Cytokine Res; 2019 Aug; 39(8):495-505. PubMed ID: 31074668 [TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor 2 deficiency ameliorates obesity-induced cardiomyopathy via inhibiting NF-κB signaling pathway. Qian C; Xu D; Wang J; Luo Y; Jin T; Huang L; Zhou Y; Cai Z; Jin B; Bao H; Wang Y Int Immunopharmacol; 2024 Feb; 128():111551. PubMed ID: 38278067 [TBL] [Abstract][Full Text] [Related]
17. Schisandrin B alleviates angiotensin II-induced cardiac inflammatory remodeling by inhibiting the recruitment of MyD88 to TLRs in mouse cardiomyocytes. Xu S; Hu C; Han J; Luo W; Huang L; Jiang Y; Samorodov AV; Wang Y; Huang J Int Immunopharmacol; 2024 Sep; 139():112660. PubMed ID: 39018688 [TBL] [Abstract][Full Text] [Related]
18. Melatonin modulates TLR4-mediated inflammatory genes through MyD88- and TRIF-dependent signaling pathways in lipopolysaccharide-stimulated RAW264.7 cells. Xia MZ; Liang YL; Wang H; Chen X; Huang YY; Zhang ZH; Chen YH; Zhang C; Zhao M; Xu DX; Song LH J Pineal Res; 2012 Nov; 53(4):325-34. PubMed ID: 22537289 [TBL] [Abstract][Full Text] [Related]
19. β-Sitosterol attenuates high-fat diet-induced intestinal inflammation in mice by inhibiting the binding of lipopolysaccharide to toll-like receptor 4 in the NF-κB pathway. Kim KA; Lee IA; Gu W; Hyam SR; Kim DH Mol Nutr Food Res; 2014 May; 58(5):963-72. PubMed ID: 24402767 [TBL] [Abstract][Full Text] [Related]